Tagged: sight diagnostics

OurCrowd Joins $27.8 Million Series C of Sight Diagnostic Creator of Point-of-Care Blood Diagnostics System

OurCrowd has joined in the Series C funding of Medtech firm Sight Diagnostics. The company is creating a lab-grade point-of-care blood diagnostics system “OLO.” This system is designed to provide patients with lab-grade blood testing results in minutes rather than days by combining AI with… Read More

Theranos Like? OurCrowd Portfolio Company Sight Diagnostics Provides Lab Quality Blood Count with Finger Prick Test

Sight Diagnostics, an Israeli Medtech firm, has launched “OLO,” an AI-based blood diagnostics device which is said to offer lab-quality “Complete Blood Count” (CBC) tests from finger prick samples at the point-of-care. Sight Diagnostics is an OurCrowd portfolio company having facilitated two investment rounds in… Read More

Send this to a friend